Circulating Tumor Cells Detected in the Tumor-Draining Pulmonary Vein Are Associated with Disease Recurrence after Surgical Resection of NSCLC

Por Crosbie, Phil A.J., Shah, Rajesh, Krysiak, Piotr, Zhou, Cong, Morris, Karen, Tugwood, Jonathan, Booton, Richard, Blackhall, Fiona, Dive, Caroline
Publicado no J Thorac Oncol (2016)

Is the canonical RAF-MEK-ERK signaling pathway a therapeutic target in SCLC?

Por Cristea, Sandra, Sage, Julien
Publicado no J Thorac Oncol (2016)

Cancer of the Esophagus and Esophagogastric Junction: An Eighth Edition Staging Primer

Por Rice, Thomas W., Ishwaran, Hemant, Ferguson, Mark K., Blackstone, Eugene H., Goldstraw, Peter
Publicado no J Thorac Oncol (2016)

Epidemiology of thymoma and associated malignancies

Por Engels, Eric A.
Publicado em 2010

MOLECULARLY TARGETED THERAPIES IN NON-SMALL CELL LUNG CANCER ANNUAL UPDATE 2014

Por Morgensztern, Daniel, Campo, Meghan J., Dahlberg, Suzanne E., Doebele, Robert C., Garon, Edward, Gerber, David E., Goldberg, Sarah B., Hammerman, Peter S., Heist, Rebecca, Hensing, Thomas, Horn, Leora, Ramalingam, Suresh S., Rudin, Charles M., Salgia, Ravi, Sequist, Lecia, Shaw, Alice T., Simon, George R., Somaiah, Neeta, Spigel, David R., Wrangle, John, Johnson, David, Herbst, Roy S., Bunn, Paul, Govindan, Ramaswamy
Publicado no J Thorac Oncol (2015)

Small Cell Lung Cancer: Can recent advances in biology and molecular biology be translated into improved outcomes?

Por Bunn, Paul A., Minna, John, Augustyn, Alexander, Gazdar, Adi, Ouadah, Youcef, Krasnow, Mark A., Berns, Anton, Brambilla, Elisabeth, Rekhtman, Natasha, Massion, Pierre P., Niederst, Matthew, Peifer, Martin, Yokota, Jun, Govindan, Ramaswamy, Poirier, John, Byers, Lauren A., Wynes, Murry W., McFadden, David, MacPherson, David, Hann, Christine L., Farago, Anna F., Dive, Caroline, Teicher, Beverly A., Peacock, Craig, Johnson, Jane E., Cobb, Melanie H., Wendel, Hans-Guido, Spigel, David, Sage, Julien, Yang, Ping, Pietanza, M. Catherine, Krug, Lee M., Heymach, John, Ujhazy, Peter, Zhou, Caicun, Goto, Koichi, Dowlati, Afshin, Christensen, Camilla Laulund, Park, Keunchil, Einhorn, Lawrence H., Edelman, Martin J., Giaccone, Giuseppe, Gerber, David E., Salgia, Ravi, Owonikoko, Taofeek, Malik, Shakun, Karachaliou, Niki, Gandara, David R., Slotman, Ben J., Blackhall, Fiona, Goss, Glenwood, Thomas, Roman, Rudin, Charles M., Hirsch, Fred. R.
Publicado no J Thorac Oncol (2016)

Axl receptor axis: a new therapeutic target in lung cancer

Por Levin, Pavel A., Brekken, Rolf A., Byers, Lauren Averett, Heymach, John V., Gerber, David E.
Publicado no J Thorac Oncol (2016)

ERBB2-mutated metastatic non-small cell lung cancer: response and resistance to targeted therapies

Por Chuang, Jody C., Stehr, Henning, Liang, Ying, Das, Millie, Huang, Jane, Diehn, Maximilian, Wakelee, Heather A., Neal, Joel W.
Publicado no J Thorac Oncol (2017)

Misclassification of Bronchioloalveolar Carcinoma with Cytologic Diagnosis of Lung Cancer

Por Raz, Dan J., Zell, Jason A., Karnezis, Anthony N., Odisho, Anobel, Ou, S-H. Ignatius, Anton-Culver, Hoda, Jablons, David M.
Publicado no J Thorac Oncol (2006)

NLST ACRIN Biomarker Repository Originating from the Contemporary Screening for the Detection of Lung Cancer Trial (NLST, ACRIN 6654):Design, Intent, and Availability of Specimens...

Por Patz, Edward F., Caporaso, Neil E., Dubinett, Steven M., Massion, Pierre P., Hirsch, Fred R., Minna, John D., Gatsonis, Constantine, Duan, Fenghai, Adams, Amanda, Apgar, Charles, Medina, Rosa M., Aberle, Denise R.
Publicado em 2010

QUANTITATIVE CT ANALYSIS, AIRFLOW OBSTRUCTION AND LUNG CANCER IN THE PITTSBURGH LUNG SCREENING STUDY

Por Wilson, David O, Leader, Joseph K, Fuhrman, Carl R, Reilly, John J, Sciurba, Frank C., Weissfeld, Joel L
Publicado em 2011

Tumor Suppressor FUS1 Signaling Pathway

Por Ji, Lin, Roth, Jack A.
Publicado em 2008

Genetic Changes in Squamous Cell Lung Cancer: A Review

Por Heist, Rebecca S., Sequist, Lecia V., Engelman, Jeffrey A.
Publicado em 2012

Histone Deacetylase Inhibitors in Malignant Pleural Mesothelioma: Preclinical Rationale and Clinical Trials

Por Paik, Paul K., Krug, Lee M.
Publicado em 2010

Pazopanib in Primary Cardiac Angiosarcoma of the Right Atrium: A Case Report

Por Schur, Sophie, Hamacher, Rainer, Brodowicz, Thomas
Publicado no Case Rep Oncol (2016)

Expanded CTCs from a Patient with ALK Positive Lung Cancer Present EML4-ALK Rearrangement along with Resistance Mutation and Enable Drug Sensitivity Testing: A Case Study

Por Zhang, Zhuo, Shiratsuchi, Hiroe, Palanisamy, Nallasivam, Nagrath, Sunitha, Ramnath, Nithya
Publicado no J Thorac Oncol (2016)

Transient asymptomatic pulmonary opacities occurring during osimertinib treatment

Por Noonan, Sinead A., Sachs, Peter B., Camidge, D. Ross
Publicado no J Thorac Oncol (2016)

Predicting malignant nodules from screening CTs

Por Hawkins, Samuel, Wang, Hua, Liu, Ying, Garcia, Alberto, Stringfield, Olya, Krewer, Henry, Li, Qian, Cherezov, Dmitry, Gatenby, Robert A., Balagurunathan, Yoganand, Goldgof, Dmitry, Schabath, Matthew B., Hall, Lawrence, Gillies, Robert J.
Publicado no J Thorac Oncol (2016)

The Src inhibitor AZD0530 blocks invasion and may act as a radiosensitizer in lung cancer cells

Por Purnell, P.R., Mack, P.C., Tepper, C.G., Evans, C.P., Green, T.P., Gumerlock, P.H., Lara, P.N., Gandara, D.R., Kung, H.J., Gautschi, O.
Publicado em 2009

Brief Report: The Kras Mutational Spectra of Chemically Induced Lung Tumors in Different Inbred Mice Mimics the Spectra of KRAS Mutations in Adenocarcinomas in Smokers vs Non-smoke...

Por Fritz, Jason M., Dwyer-Nield, Lori D., Russell, Bridgette M., Malkinson, Alvin M.
Publicado em 2010